化学
神经退行性变
水解酶
酶
细胞生物学
小分子
药物发现
酶激活剂
生物化学
活动站点
程序性细胞死亡
结构-活动关系
功能(生物学)
拟肽
生物物理学
酶抑制剂
蛋白质结构
结合位点
对接(动物)
血浆蛋白结合
双环分子
立体化学
作者
Steven K. Albanese,Brittany E. Hopkins,Andrea M. Olland,Alexis Fairman,Nadim S. Shaikh,Shulu Feng,Mahesh Thakkar,Andreas Verras,Alexey Dementiev,Ward G. Walkup,Christian Atsriku,Harathi D. Srinivas,Wayne Allen,Khuram Ashraf,Pieter H. Bos,Peng Hsiao,Kyle G. Kroeck,Zhijian Liu,Anu Nagarajan,Christopher T. Szlenk
标识
DOI:10.1021/acs.jmedchem.6c00352
摘要
Sterile Alpha and TIR Motif Containing 1 (SARM1) is an NAD+ hydrolase enzyme implicated in neurological diseases with prominent axonopathies. A reported method for SARM1 inhibition involves the design of small molecules bearing reactive heterocyclic warheads, which intercept the hydrolysis of NAD+ in the active site of SARM1 and subsequently inhibit enzymatic function of the TIR domain. Herein, we describe the discovery of a series of bicyclic SARM1 inhibitors, initially identified via a unique workflow for free-energy perturbation (FEP+) simulations. Subsequent hit expansion efforts identified potent and cell-active inhibitors with slow off-rates, which impart a unique conformational state of W662 in the SARM1 catalytic site, as assessed via X-ray crystallography. Finally, we discuss an identified liability associated with substrate-based SARM1 inhibitors such as 19, whereby insufficient target engagement results in an increase in biomarkers of neurodegeneration at low doses in vivo and exacerbates neuronal degeneration and cell death in vitro.
科研通智能强力驱动
Strongly Powered by AbleSci AI